Dr. Reddy's Laboratories
147 hedge funds and large institutions have $1.07B invested in Dr. Reddy's Laboratories in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 41 increasing their positions, 51 reducing their positions, and 23 closing their positions.
27% more call options, than puts
Call options by funds: $464K | Put options by funds: $366K
4% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 23
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 148 → 147 (-1)
3% less capital invested
Capital invested by funds: $1.11B → $1.07B (-$32.6M)
1.41% less ownership
Funds ownership: 50.99% → 49.59% (-1.4%)
20% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 51
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$39.9M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
+$33.7M |
| 3 |
BlackRock
New York
|
+$11.9M |
| 4 |
Lazard Asset Management
New York
|
+$4.01M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.81M |
Top Sellers
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$41.7M |
| 2 |
BAMCO Inc
New York
|
-$25M |
| 3 |
Morgan Stanley
New York
|
-$16M |
| 4 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
-$9.93M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$6.51M |
RDY Hedge Fund Activity: Q4 2021 in Review
147 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2021, worth a combined $1.07B — down 2.9% from $1.11B a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new RDY positions and 23 closed out — a net gain of 1 holder — while 41 added to existing stakes and 51 trimmed.
The largest buyer was Ameriprise, opening a new position worth an estimated $39.9M. The largest seller was Bank of Montreal, cutting an estimated $41.7M.
- 147 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2021, down from 148 in Q3 2021.
- Funds reported $1.07B of Dr. Reddy's Laboratories stock for Q4 2021, down 2.9% quarter-over-quarter.
- 24 funds opened new Dr. Reddy's Laboratories positions in Q4 2021 and 23 closed out, a net change of +1 holder.
- The largest Dr. Reddy's Laboratories buyer in Q4 2021 was Ameriprise, an estimated $39.9M added.
- The largest Dr. Reddy's Laboratories seller in Q4 2021 was Bank of Montreal, an estimated $41.7M sold.
Based on aggregated 13F filings for Q4 2021.